biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs > hmm...that's odd

<< Previous

Bullboard Posts

Next >>

Comment by MBT123on Nov 24, 2020 2:37am

190 Views

Post# 31958617

RE:RE:hmm...that's odd

When you hire a retired a PR guy who may or not be living in a trailer in B.C. ....who obviously has zero and I mean zero actually triple zero maybe even negative effect on what ever he says on the share price..You would think with all your comparisons and "facts" and "projections" we would be getting gobbled up by American investors...But nope you and the good ol Dr.R will send out some other deal with no timelines that falls on deaf ears with lots of false hopes..

<< Previous

Bullboard Posts

Next >>

Paramount Resources signs $3.32 billion asset sale